Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis

International Journal of Cancer

Volumn 74, Issue 5, 1997, Pages 502-507

  Kang, Soon Myoung ^a   Maeda, Kiyoshi ^a   Onoda, Naoyoshi ^a   Chung, Yong Suk ^a   Nakata, Bunzo ^a   Nishiguchi, Yukio ^a   Sowa, Michio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; COLORECTAL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030707635     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971021)74:5<502::AID-IJC4>3.0.CO;2-7     Document Type: Article

References (21)

1. BAKER, S.J., MARKOWIZ, S., FEARON, E.R., WILLSON, J.K.V. and VOGELSTEIN, B., Suppression of human colorectal carcinoma cell growth by wild-type p53. Science, 249, 912-915 (1990).
2. BROWN, L.F., BERSE, B., JACKMAN, R.W., TOGNAZZI, K., MANSEAU, E.J. and SENGER, D.R., Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53, 4727-4735 (1993).
3. CAMPO, E., DE LA CALLE-MARTIN, O., MIQUEL, R., PALACIN, A., ROMERO, M.F., VIVES, J., CARDESA, A. and YAGUE, J., Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res., 51, 4436-4442 (1991).
4. CUNNINGHAM, J., LUST, J.A., SCHAID, D.J., BREN, G.D., CARPENTER, H.A., RIZZA, E., KOVACH, J.S. and THIBODEAU, S.N., Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res., 52, 1974-1980 (1992).
5. DAMERON, K.M., VOLPERT, O.V., TAINSKY, M.A. and BOUCK, N., Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science, 265, 1582-1584 (1994).
6. FARMER, G., BARGONETTI, J., ZHU, H., FRIEDMAN, P., PRYWES, R. and PRIVES, C., Wild-type p53 activates transcription in vitro. Nature (Lond.), 358, 83-86 (1992).
7. FEARON, E.R. and VOGELSTEIN, B., A genetic model for colorectal tumorigenesis. Cell, 61, 759-767 (1990).
8. FOLKMAN, J., What is the evidence that tumors are angiogenesis dependent? J. nat. Cancer Inst., 82, 4-6 (1990).
9. FOLKMAN, J., Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature (Med.), 1, 27-31 (1995).
10. KANG, S.M. and 12 OTHERS, Vascular endothelial growth factor expression correlates with hematogenous metastasis and prognosis in colorectal carcinoma. Oncol. Rep., 4, 381-384 (1997).
11. KASTAN, M.B., ONYEKWERE, O., SIDRANSKY, D., VOGELSTEIN, B. and CRAIG, R.W., Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311 (1991).
12. KIESER, A., WEICH, H.A., BRANDNER, G., MARME, D. and KOLCH, W., Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene, 9, 963-969 (1994).
13. LANE, D.P., p53, guardian of the genome. Nature (Lond.), 358, 15-16 (1992).
14. LEUNG, D.W., CACHIANES, G., KUANG, W.J., GOEDEL, D.V. and FERRARA, N., Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306 (1989).
15. MAEDA, K., CHUNG, Y.S., OGAWA, Y., TAKATSUKA, S., KANG, S.M., OGAWA, M., SAWADA, T. and SOWA, M., Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer, 77, 858-863 (1996).
16. MAEDA, K., CHUNG, Y.S., TAKATSUKA, S., OGAWA, Y., SAWADA, T., YAMASHITA, Y., ONODA, N., KATO, Y., NITTA, A., ARIMOTO, Y., KONDO, Y. and SOWA, M., Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J. clin. Oncol., 13, 477-481 (1995).
17. MUKHOPADHYAY, D., TSIOKAS, L. and SUKHATME, V.P., Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res., 55, 6161-6165 (1995a).
18. MUKHOPADHYAY, D., TSIOKAS, L., ZHOU, X.M., FOSTER, D., BRUGGE, J.S. and SUKHATME, V.P., Hypoxia induction of human vascular endothelial growth factor expression through c-Src activation. Nature (Lond.), 375, 577-581 (1995b).
19. STARZYNSKA, T., BROMLEY, M., GHOSH, A. and STERN. PL., Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Brit. J. Cancer, 66, 558-562 (1992).
20. VAN MEIR, E.G., POLVERINI, P.J., CHAZIN, V.R., Su HUANG, H.J., DE TRIBOLET, N. and CAVENEE, W.K., Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature (Genet.), 8, 171-176 (1994).
21. YIN, Y., TAINSKY, M.A., BISCHOFF, F.Z., STRONG, L.C. and WAHL, G.M., Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70, 937-948 (1992).